Riyadh to host global biotech summit in September 2026

Riyadh will host the fourth Riyadh Global Medical Biotechnology Summit from Sept. 14-16, 2026, bringing together scientists, investors, policymakers and health innovators from more than 70 countries. Organizers say the event is designed to support Saudi Arabia's biotech strategy and its goal of adding $34.6 billion to non-oil GDP by 2040.

Why it matters: - RGMBS 2026 is positioned as a major convening point for Saudi Arabia's biotechnology push. - The summit is tied to the kingdom's national biotechnology strategy and its 2040 target of contributing $34.6 billion to non-oil GDP. - The event is meant to connect research, investment, regulation, manufacturing and talent development in one place.

What happened: - Riyadh Global Medical Biotechnology Summit 2026 will take place in Riyadh, Saudi Arabia, from Sept. 14-16, 2026. - The fourth edition will bring together scientists, investors, policymakers and health innovators across six themes: artificial intelligence in biotechnology, multi-omics and localization, biotech investment, immunology, bioengineering and synthetic biology, and biotech workforce development. - Organizers expect more than 15,000 visitors, more than 100 local and international speakers, 200 biotechnology and health care brands, and more than 80 exhibitor entities from government and industry. - Delegations from more than 70 countries are expected to attend. - The summit is targeting more than 65 agreements and memorandums of understanding during the three-day event.

The details: - The scientific program spans the full biomedical innovation pipeline, from population-scale genomics and AI-driven drug discovery to domestic biomanufacturing, regulatory science, commercialization and investment. - The event is overseen by the Ministry of National Guard Health Affairs. - King Abdullah International Medical Research Center and King Saud bin Abdulaziz University for Health Sciences are hosting the summit. - The Ministry of Investment, Invest Saudi and the Saudi Data and AI Authority are serving as strategic partners. - The summit includes scientific sessions, panel discussions, workshops and agreement signings. - International delegates will see regulatory frameworks, manufacturing infrastructure and research capacity that Saudi Arabia is building from discovery to commercial production. - Registration is now open for delegates, exhibitors and industry partners. - The full scientific program, speaker list and event information are available at more information. - The summit will use the hashtag #RGMBS2026.

Between the lines: - The summit reflects a broader effort to build a biotech ecosystem rather than focus on a single research area. - Leadership says sustainable progress depends on scientific infrastructure, clinical trial networks, biomanufacturing, digital platforms and national talent development. - The theme for this year's summit is "Building the Foundation of Biotech Excellence," signaling a shift from global reach to deeper institutional capacity. - The event also highlights partnerships with Harvard University in translational oncology, AstraZeneca in gene therapy and Peking University in drug discovery.

What's next: - Organizers will continue to add participants, speakers and exhibitors ahead of the September summit. - The event is expected to produce new deals, memorandums and business or research connections over the three-day program. - The summit will serve as a showcase for Saudi Arabia's biotech priorities and its expanding infrastructure for research and manufacturing.

The bottom line: - Riyadh is using RGMBS 2026 to signal that biotechnology is becoming a strategic national growth sector, not just a conference topic.